Portal de Periódicos da CAPES

Serotonin and Mood Disorders

1990; Slack Incorporated (United States); Volume: 20; Issue: 10 Linguagem: Inglês

10.3928/0048-5713-19901001-09

1938-2456

Robert N. Golden, John H. Gilmore,

Neurotransmitter Receptor Influence on Behavior

Serotonin in Psychiatric DisordersSerotonin and Mood Disorders Robert N Golden, MD, , and , MD John H Gilmore, MD, , MD Robert N Golden, MD and John H Gilmore, MD Psychiatric Annals, 2013;20(10):580–586Published Online:October 01, 1990https://doi.org/10.3928/0048-5713-19901001-09Cited by:13View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Lewis A. Melancholia: historical review. In: Lewis A1 ed. The Stale of Psychiatry: Essays arid Addresses. New York, NY: Science House; 1967:64-73. Google Scholar2. Golden RN, Potter WZ. Neurochemical and neuroendocrine dysregulation in affective disorders. Psychialr Clin North Am. 1986:9:313-327. Google Scholar3. Meltzer HY Lowy MT The serotonin hypothesis of depression. In: Meltzer HY ed. Psychopharmacology: The Third Cenerà lion of Progress. New Vbrk, NY: Raven Press Pubs; 1987:513-526. Google Scholar4. Goodwin FK. Ebert MH. Buiinev WTJt. Menial effects of reserpine in man: a review. In: Shader Rl. ed. Psychiatric Complications a/ Medical Drugs. New York, NY: Raven Press Piths; 1972:73-101. Google Scholar5. Stanley M, Virigilio J, Gershon S. Trinateci Imipramine binding sites are decreased in the frontal cortex of suicides. Science. 1982; 216:1337-1339. Google Scholar6. Mann JJ1 Stanley M. McBt irle PA. McEwen BL. Increased serotonin., and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 1986; 43:954-959. Google Scholar7. Nemeroff CB, Knighi DL1 Krishnan KRR. et al. Marked reduction in ? lie number of platelet trinateci Imipramine binding sites in geriatric depression. Arch Cen Psychiatry. 1988; 45:919-923. Google Scholar8. Baldessaiini RJ. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psyclmpharmarol Bull. 1984; 20:224-239. Google Scholar9. Shopsin B, Friedman E. Gershon S. Parachlorophenylalanine reversal of tranylcypromine effect in depressed patients. Arch Gen. Psychiatry. 1976; 33:811-822. Google Scholar10. Delgado PL, Charney DS. Price LH, Aghajanian GK. Lantus IL Heninger GR. Serotonin function and the mechanism ol antidepressant action: reversal of antidepressani-induced remission by rapid depletion ol plasma. Arch Gen Psychiatry. 1990; 17:411-418. Google Scholar11. Prange AJJr, Wilson IC, Lynn CW, Alltop LB. Siikeleathcr RA. L-tryptophan in mania: contribution to a permissive hypothesis of affective disorders. Arch Gen Psychiatry. 197 I: 30:56-62. Google Scholar12. Meltzer HY Umbcrkoman Wiita B. Robertson A, Tricou BJ, D)WV M, Perline R. Effect of hydroxytryplophan on serum Cortisol levels in major affective disorders: enhanced response in depression and mania. Arch Gen Psychiahy. 1984; 41 :366-374. Google Scholar13. Siever LJ, Murph) DL. Slater S, Dc La Yega E, Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivi ty in depression. Life Sci. 1984; 34:1029-1039. Google Scholar14. Heninger GR, Charney DS. Sternberg DE. Serotonergic function in depression: prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry. 1984;41:398-402. Google Scholar15. Charney DS. Heninger GR, Sternberg DE. Serotonin function and mechanism of action of antidepressant treatment: effects of amitryptyline and depression. Arch Gen Psychiatry. 1984; 41:358-365. Google Scholar16. Golden RN. Hsiao J1 Lane E. el al. Abnormal neuroendocrine responsivi tv to acme intravenous clomipramine challenge in depressed patients. Psychiatry Res. 1990: 31:39-47. Google Scholar17. Golden RN, Rtiegg R, Brown T, et al. Abnormal neuroendocrine responsivi tv lo clomipramine in depression. Presented at the- American College of Neuropsychopharmacology Annual Meeting; December. 1989; Maui, Hawaii. Google Scholar18. Golden RN. Ruegg R, Brown T, et al. Abnormal neuroendocrine responsivity to clomipramine. In press. Google Scholar19. Meltzer HY Perline R, Tricou BJ. Lowy M. Robertson A. Effect of hydroxytryptophan on serum levels in major affective disorders: relation to suicide·, psychosis, and depressive symptoms. Arch Gen Psychiatry. 1984: 41:379-387. Google Scholar20. Van Praag HM, Lenins C, Kahn R. Hormonal probes of central serotonergic activity: do they really exist? Biol Psychiatry. 1989: 22:86-98. Google Scholar21 Tang SW, Helmeste DM. Serotonin receptors in affective disorders. In: Sen AIv Lett T, eds. Receptors and Ligands in Psychiahy. New York. NY: Cambridge University Press; 1988:245-270, Google Scholar22. Blier P. DeMontigny C, Chaput Y Modifications of the serotonergic system by antidepressant treatments: implication for the therapeutic response in major depression. J Clin Psychopharmacol. 1989: 7:24s-35s. Google Scholar23. Willner P. Antidepressants and serontonergic neurotransmission: an integrative review. Psychopharm. 1985: 85:389404. Google Scholar24. Charney DS. Heninger GR, Sternberg DE. Serotonin function and mechanism of action of antidepressant treatment: effects of amitryptyline and desipramine. Arch Gen Psychiatry. 1984: 41:359-365. Google Scholar25. Price LH. Charney DS. Heninger GR. Effects of tranylcypromine treatment on neuroendocrine, behavioral, and autonomic responses to tryptophan in depressed patients. Life Sci. 1985: 37:808818. Google Scholar26. Meltzer HY Lowy M. Robertson A1 Goodnick P, Perline R. Affect of 5hydroxytryplophan on serum Cortisol levels in major affective disorders, III: effect of antidepressants and lithium carbonate. AnA Gen Psychiahy. 1981: 41:391-397. Google Scholar27. Golden RN. Ruegg R, Corrigan M, Gilmore J. Miller HL, Carson S. Serotonergic function in depression. Presented at the 143rd Annual Meeting of die American Psychiatric Association: Mav 1990; New York, NY Google Scholar28. DeMontigny C1 Conmover G, Morissette R. l.anglois R, Caille G. Lithium carbonate addition in tricyclic aniidepressantresistant unipolar depression: correlations with the neurobiologie actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry. 1983; 40:1327-1334. Google Scholar29. Heninger GR, Charney DS, Sternberg DE. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Arch Gen Psychiahy. 1983; 40:1335-1342. Google Scholar30. Rudorfer MV. Scheinin M1 Kam m F, Ross RJ. Potter WZ, Unnoila M. Reduction of norepinephrine by serotonergic drug in man. Biol Psychiahy. 1984: 19:179-193. Google Scholar31 Golden RN. Janowsky DS. Biological theories of depression. In: Woman B. Strieker G. eds. Affective Disorders: facts, Theories, and Treatment. New York. NY: John Wiley & Sons. In press. Google Scholar32. Potter WZ, Scheinin M, Golden RN, et al. Selective antidepressants and cerebrospinal fluid: lack of specificity on norepinephrine and serotonin metabolites. Arch Gen Psychiahy. 1985; 42:1 171-1 177. Google Scholar33 Hsiao JK, Agren II, BartkoJJ, Rudorfer YIY, Linnoila Yl. Potter WZ. Monoamine neurotransmitter interactions and the prediction of antidepressant response. Arch Gen Psychiahy. 1987: 44:1078-1085. Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Singhal G and Baune B (2020) Inflammatory Abnormalities in Major Depressive Disorder Major Depressive Disorder, 10.1016/B978-0-323-58131-8.00006-9, (75-89), . Netter P and Hennig J (2017) Fatigue and stress reactivity are differently related to cigarette craving and hormone responses to neurotransmitter related drugs in nicotine deprived smokers, Personality and Individual Differences, 10.1016/j.paid.2017.05.021, 118, (77-83), Online publication date: 1-Nov-2017. Sassarini D (2016) Depression in midlife women, Maturitas, 10.1016/j.maturitas.2016.09.004, 94, (149-154), Online publication date: 1-Dec-2016. Hashemi S, Ramezani Tehrani F, Mohammadi N, Rostami Dovom M, Torkestani F, Simbar M and Azizi F (2016) Comparison of Metabolic and Hormonal Profiles of Women With and Without Premenstrual Syndrome: A Community Based Cross-Sectional Study, International Journal of Endocrinology and Metabolism, 10.5812/ijem.28422, 14:2 Zotti M, Colaianna M, Morgese M, Tucci P, Schiavone S, Avato P and Trabace L (2013) Carvacrol: From Ancient Flavoring to Neuromodulatory Agent, Molecules, 10.3390/molecules18066161, 18:6, (6161-6172) Bromberger J and Kravitz H (2011) Mood and Menopause: Findings from the Study of Women's Health Across the Nation (SWAN) over 10 Years, Obstetrics and Gynecology Clinics of North America, 10.1016/j.ogc.2011.05.011, 38:3, (609-625), Online publication date: 1-Sep-2011. Kosten T and Kehoe P (2007) Early Life Stress and Vulnerability to Addiction Stress and Addiction, 10.1016/B978-012370632-4/50008-5, (105-126), . Barkan T, Peled A, Modai I, Weizman A and Rehavi M (2006) Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals, European Neuropsychopharmacology, 10.1016/j.euroneuro.2005.11.008, 16:6, (429-436), Online publication date: 1-Aug-2006. Dawson L, Hughes Z, Starr K, Storey J, Bettelini L, Bacchi F, Arban R, Poffe A, Melotto S, Hagan J and Price G (2006) Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity, Neuropharmacology, 10.1016/j.neuropharm.2006.01.010, 50:8, (975-983), Online publication date: 1-Jun-2006. FRUZZETTI A, SHENK C and HOFFMAN P (2005) Family interaction and the development of borderline personality disorder: A transactional model, Development and Psychopathology, 10.1017/S0954579405050479, 17:04, Online publication date: 1-Dec-2005. Moret C and Briley M (2000) The possible role of 5-HT1B/D receptors in psychiatric disorders and their potential as a target for therapy, European Journal of Pharmacology, 10.1016/S0014-2999(00)00581-1, 404:1-2, (1-12), Online publication date: 1-Sep-2000. Keane P and Soubrié P (2000) Animal Models of Integrated Serotoninergic Functions: Their Predictive Value for the Clinical Applicability of Drugs Interfering with Serotoninergic Transmission Serotoninergic Neurons and 5-HT Receptors in the CNS, 10.1007/978-3-642-60921-3_27, (707-725), . O'Toole S and Johnson D (1997) Psychobiology and psychopharmacotherapy of unipolar major depression: A review, Archives of Psychiatric Nursing, 10.1016/S0883-9417(97)80003-9, 11:6, (304-313), Online publication date: 1-Dec-1997. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 6.5 MB Published online10/01/90